Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.

“It all started when I was 58. I didn’t have any symptoms – apart from needing to go to the toilet a lot. At night, I was trying to pee, couldn’t, then went back to bed and the next minute needed to ...

New research has identified a way to predict resistance to a cancer drug commonly used to treat advanced prostate cancer. Using samples from more than 200 men, researchers found a significant ...

Experts at The Institute of Cancer Research, London, have responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme ...

The Institute of Cancer Research, London, has received the highest national honour in UK further and higher education for its pioneering radiotherapy research. The Queen Elizabeth Prizes for Higher ...

We've selected a range of discoveries from 2024/25 – chosen because they illustrate the quality and breadth of our basic, translational and clinical research and our ambitions under the ICR's research ...

Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread ...

Prostate cancer guidelines should change so that all men from the age of 40 with mutations in either the BRCA1 or BRCA2 gene are offered regular PSA testing to detect early signs of the disease, ...

Up to two in five advanced prostate cancer patients could be treated with a combination of two targeted drugs, according to new research. Findings by a team of scientists at The Institute of Cancer ...

Suffering from psychological stress could further increase cancer risk in those already genetically predisposed to the disease, according to new research. The findings show that the stress hormone ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new research. The nationwide TORPEdO trial funded by ...